Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 280 participants.

Also called NCT06841965

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06841965
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06841965. Randomized; double masking; primary purpose treatment. Start 2025-03-01 (anticipated); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer
Condition
Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
Intravenous thrombolysis
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct06841965
Content hash
24ef50a16595bcee9025715b802b35520128ba564eaa70a25be5fc3809ede940